The Procter & Gamble Company (PG) Stock Price, Analysis & Forecast 2026

NASDAQ
PG
The Procter & Gamble Company
Updated 2026-05-07

The Procter & Gamble Company (PG) Stock Price, Analysis & Forecast 2026

Current price
$146.42 ▲ 0.25%
Market cap$342.84B
ConsensusBuy
Price target$161.88 +10.0%
52-week range137.62-170.99
Next earnings2026-08-04

PG interactive stock chart

Key statistics

Overall score

✓ Buy
Valuation

8.3/10

Financial health

7.1/10

Profitability

10/10

Growth

5.1/10

Analyst consensus

5.4/10

Current price
$146.42 ▲ 0.25%
NASDAQ · Live

52-week range
137.62-170.99
Low29%High
Short pressure
59.8%
Moderate short activity
Revenue TTM
$84.28B
↑ 0.3% YoY

Market cap
$342.84B
Large-cap

Next earnings
2026-08-04
EPS est. $1.46
Market cap$342.84BToday’s volume24,158
Revenue (TTM)$84.28BAvg. daily volumeN/A
P/E ratio21.31xToday’s range146.4 – 147.99
Debt / equity0.68x52-week range137.62-170.99
Net margin19.22%Beta0.398x
ROEN/A%Current ratio0.73x
Dividend & yield$4.2594 (0.03%)Next earnings2026-08-04
FCF yield4.39%FMP ratingA-
DCF fair value$225.17 (52.9%)Revenue growth0.3%
Other Consumer Defensive stocks to watchAll stocks →

See also: CL · CLX · COST · EPC · KMB · All Household & Personal Products stocks

Is PG a good stock to buy in 2026?

Cautious Buy
Key signals
✓ 53.8% analyst Buy✓ +10.0% upside to $161.88✓ $342.84B large-cap✓ Short pressure 59.8%
✗ P/E 21.31x (sector: 20x)

The Procter & Gamble Company (PG) presents a mixed signal for investors in 2026. While its P/E ratio of 21.31x is slightly above the Household & Personal Products sector average of 20x, its Discounted Cash Flow (DCF) model suggests a fair value of $225.17, indicating it is currently undervalued by 52.9%. Furthermore, a strong consensus with 53.8% analyst buy ratings points towards positive sentiment for PG stock, suggesting it could be a cautious buy for long-term investors.

✓ Undervalued by DCF
✗ Slowing Revenue Growth
– Cautious Buy Signal

2026 PG price scenarios

Based on analyst consensus of $161.88 from 52 analysts. Not a prediction by Alert Invest.

Pessimistic$142
-3.6%

Key risks:

  • Intensified competition leading to market share erosion and pricing pressures on key brands.
  • Significant disruptions in global supply chains or a sustained increase in raw material costs, compressing already tight margins.
  • A broader economic downturn resulting in weaker-than-expected consumer spending for discretionary household and personal care products.
1.9% of analysts · sell

Base case$161.88
+10.0% upside

Assumes:

  • PG effectively leverages its robust brand portfolio to maintain stable organic sales, progressing towards its forward revenue estimate of $100.1B.
  • The company continues to implement cost-saving initiatives and maintains pricing power, supporting a forward EPS of $8.40237.
  • Procter & Gamble’s consistent dividend policy remains attractive to long-term income investors, providing a floor for the PG stock price.
44.2% hold · consensus view

Optimistic$179
+21.6% upside

Requires:

  • Breakthrough innovation or successful new product launches that significantly accelerate market share gains and revenue growth beyond current modest projections.
  • Greater-than-expected effectiveness of premiumization strategies or aggressive cost efficiencies that lead to a notable expansion in profit margins.
  • A stronger-than-anticipated global economic recovery, boosting consumer confidence and spending across all of P&G’s product categories.
0.0% of analysts · strong buy

How does PG compare?

Side-by-side valuation, growth, and analyst ratings vs top Consumer Defensive competitors.

About The Procter & Gamble Company (PG)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Led by CEO Shailesh G. Jejurikar, Procter & Gamble employs approximately 108,000 individuals globally, leveraging its extensive workforce to manage a vast portfolio of trusted household and personal care brands. The company’s distinctive strengths lie in its unparalleled brand recognition, global distribution network, and a long history of product innovation, which together foster deep consumer loyalty and resilience in various economic climates.

PG competitive moat and business analysis

Procter & Gamble’s competitive advantage is largely derived from its massive scale, brand equity, and extensive distribution capabilities. With a net margin of 19.22% and a gross margin of 50.33%, the company demonstrates strong profitability in the highly competitive consumer defensive sector. While specific ROE/ROIC data is not available, these robust margins suggest efficient operations and a strong ability to convert sales into profit, a hallmark of companies with significant economic moats. This allows PG stock to maintain consistent performance even during challenging periods.

The provided data for fiscal year 2025 does not include a specific breakdown of revenue by segments or geographical regions. However, P&G’s diversified product portfolio, spanning beauty, grooming, healthcare, fabric & home care, and baby, feminine & family care, inherently provides resilience. Its global presence also mitigates risks associated with over-reliance on any single market.

Despite its robust competitive moat, P&G’s revenue growth has been modest at +0.3% year-over-year. This reflects the mature nature of many of its markets and the sheer size of the company. The moat’s trend is focused more on maintaining stability and profitability rather than rapid top-line expansion, which is typical for established consumer staples giants. Investors in PG stock often prioritize consistent dividends and defensive characteristics over aggressive growth.

When comparing Procter & Gamble to its peers like Colgate-Palmolive (CL), The Clorox Company (CLX), and Costco Wholesale (COST), PG generally stands out due to the sheer breadth and depth of its brand portfolio. While peers may excel in specific niches, P&G’s comprehensive market presence and diversification across multiple household product categories provide a broader revenue base and arguably greater long-term stability for PG stock holders.

The Procter & Gamble Company analyst rating

Based on 52 analysts. 53.8% rate PG Buy or Strong Buy.

Buy / Hold / Sell breakdown

BUY
52 analysts

Buy53.8%

Hold44.2%

Sell1.9%

12-month price target range
$142$161.88$179
LowConsensusHigh
Current price$147.23Below all targets
To consensus
+10.0%
To high
+21.6%
Analysts
52
Buy
Based on 52 analyst ratings
Consensus target
$161.88
+10.0% upside
Strong buy

0.0%

Buy

53.8%

Hold

44.2%

Sell

1.9%

Strong sell

0.0%

A 53.8% buy rating for PG stock is generally considered a strong endorsement, particularly for a mature, defensive sector company like Procter & Gamble. While less volatile stocks might often gather more “Hold” ratings, a majority “Buy” suggests analysts see significant upside potential or consistent stability that makes it an attractive investment.

PG financial scorecard

Comprehensive ranking of PG across four financial dimensions.

Financial strength

6.0/10

MetricValueSignal & strength
Debt / equity0.68x
Moderate

Current ratio0.73x
Tight

FCF yield4.39%
Fair

DCF vs price+52.9%
Undervalued

FMP debt score2/5
Below avg

Profitability rank

10/10

MetricValueSignal & strength
Gross margin50.33%
Excellent

Net margin19.22%
Good

EBITDA margin26.82%
Good

ROEN/A
Low

ROAN/A
Low

FMP ROE score5/5
Above avg

Growth rank

4.1/10

MetricValueSignal & strength
Revenue growth YoY+0.3%
Slowing

Revenue (TTM)$84.28B
Large scale

Forward EPS est.$8.40237
Analyst consensus

Forward revenue$100.1B
Analyst consensus

FMP DCF score4/5
Above avg

Valuation rank

4.0/10

MetricValueSignal & strength
P/E ratio21.31x
Fair

P/B ratio6.52x
Expensive

P/S ratio3.95x
Fair

DCF fair value$225.17
Undervalued

FMP P/E score3/5
Average

FMP overall4/5
Strong

Is PG undervalued or overvalued?

DCF $225.17Fair valuePremiumHigh $179
CheapPremiumRich

$147.23
P/E ratio
21.31x

Fair

P/B ratio
6.52x

Expensive

P/S ratio
3.95x

Fair

DCF value
$225.17

Undervalued

FCF yield
4.39%

Fair

Analyst tgt
$161.88

+10.0% upside

The valuation for PG stock presents a somewhat mixed picture, with different metrics suggesting varying conclusions. Its trailing P/E ratio of 21.31x is slightly higher than the Household & Personal Products sector average of 20x, indicating it might be trading at a slight premium compared to its immediate peers. This premium could be justified by its strong brand portfolio and consistent profitability.

However, a Discounted Cash Flow (DCF) analysis reveals a fair value of $225.17, which implies that PG stock is significantly undervalued by 52.9% relative to its current trading price. This substantial difference suggests that, based on future cash flow projections, P&G could offer considerable upside for long-term investors. Other metrics like the P/B ratio at 6.52x appear expensive, while the P/S ratio of 3.95x suggests a fair valuation.

PG financial health & key metrics

MetricPGSector avgSignal
P/E ratio21.31x20xFair (Slightly above sector)
Net margin19.22%Excellent
ROE / ROICN/AN/A
Debt / equity0.68xModerate
FCF yield4.39%Fair
Revenue growth0.3%Slowing
DCF fair value$225.17Undervalued

For value investors, PG stock demonstrates robust financial health with an excellent net margin of 19.22%, indicating strong operational efficiency and pricing power. While its P/E ratio is slightly above the sector average, the significant undervaluation suggested by its DCF fair value of $225.17 highlights a potential buying opportunity. The moderate debt-to-equity ratio of 0.68x and fair FCF yield of 4.39% further support its stability, despite a modest revenue growth of 0.3%, positioning P&G as a solid defensive investment.

The Procter & Gamble Company earnings history & next report

The Procter & Gamble Company reported EPS of $1.59, beating estimates by 1.92%. Next earnings: 2026-08-04 with EPS estimate of $1.46.

When The Procter & Gamble Company reports its next earnings on 2026-08-04, investors should closely watch for details on organic sales growth across its key segments, particularly in Beauty and Healthcare, as well as any updates to full-year guidance. Any commentary on input cost inflation and pricing strategies will be crucial in understanding how the company plans to maintain its impressive net margins, especially with an EPS estimate of $1.46 for the upcoming quarter.

PG daily short volume

Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.

Short ratio
59.8%
Moderate short activity
Short volume
1.81M
shares sold short
Total volume
3.02M
FINRA-reported
Short ratio barSession: 2026-05-06
0%59.8% shorted100%
MetricValueContext
Short volume ratio59.8%40-60% = moderate
Shares sold short1.81MFINRA-reported for 2026-05-06
Total reported volume3.02MAll FINRA ATS + OTC volume
Exempt short volume6.6KMarket-maker / arbitrage exempt trades
SignalModerate short activityFINRA CNMS Consolidated

PG insider trading activity

Corporate insiders must report trades to the SEC within two business days.

Insider signal
Neutral
Insider activity is balanced between buying and selling.
Total purchases
$0
0 transactions
Total sales
$0
0 transactions
DateInsiderRoleTypeSharesPriceValueFiling
2026-04-01Gama PaulOfficer: Ceo- Health CareSale0N/A$0SEC
2026-04-01Gama PaulOfficer: Ceo- Health CareSale0N/A$0SEC
2026-04-01Gama PaulOfficer: Ceo- Health CareSale58N/A$0SEC
2023-02-28Gama PaulOfficer: Ceo- Health CareSale6,807$113.23$770,757SEC
2023-09-29Gama PaulOfficer: Ceo- Health CareSale8,250$139.24$1,148,730SEC
2023-09-15Gama PaulOfficer: Ceo- Health CareSale7,482$138.63$1,037,230SEC

Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice

Recent PG analyst rating changes

FirmPreviousNew ratingDateAction
UBSBuyBuy2026-04-27Reiterated
Evercore ISI GroupIn LineIn Line2026-04-27Reiterated
Wells FargoOverweightOverweight2026-04-27Reiterated
TD CowenHoldHold2026-04-27Reiterated
JP MorganOverweightOverweight2026-04-17Reiterated

The Procter & Gamble Company stock news today

No major news for The Procter & Gamble Company (PG) has been reported this week. Investors are advised to monitor official company announcements and financial reports for the latest developments regarding PG stock.

How does PG compare to its peers?

For investors considering PG stock, it’s insightful to compare its standing against other prominent players in the Consumer Defensive sector. While each company has its unique focus, they all vie for consumer spending on essential household and personal care products. Here’s how Procter & Gamble stacks up against some key competitors.

CL

Colgate-Palmolive Company is a global consumer products company focused on oral care, personal care, home care, and pet nutrition. It boasts strong brand recognition in toothpaste and soaps, similar to P&G’s household staples.

PG vs CL

CLX

The Clorox Company is a manufacturer and marketer of consumer and professional products, primarily focused on cleaning, household, and lifestyle categories. Known for its strong bleach brand, Clorox competes with P&G in specific home care segments.

PG vs CLX

COST

Costco Wholesale Corporation operates a chain of membership warehouses, offering a wide selection of branded and private-label products at low prices. While a retailer, Costco’s strength in consumer goods distribution makes it an indirect competitor and a key sales channel for companies like P&G.

PG vs COST

Alert Invest · Free Newsletter

Get alerts when top investors buy a stock!

Track when institutional investors, insiders, and analysts change their positions. Alert Invest sends you a data-driven brief the moment it happens — free, every week.

  • Institutional & insider moves
  • Analyst upgrades & downgrades
  • 100% free — unsubscribe anytime

Get free investor alerts →

FAQ — The Procter & Gamble Company (PG) stock

As of 2026-05-07, PG market cap is $342.84B.

PG P/E is 21.31x vs Household & Personal Products sector avg 20x. This makes PG stock slightly expensive relative to the sector average.

Based on 52 analysts, consensus target is $161.88 (+10.0% upside). High: $179. Low: $142. Not a prediction by Alert Invest.

With 53.8% analyst Buy ratings and a +10.0% upside to the consensus target of $161.88, PG stock shows positive analyst sentiment. While its P/E of 21.31x is slightly above the sector average of 20x, its strong brand portfolio and consistent performance make it an appealing long-term hold for many investors, though this is not investment advice.

Based on a P/E ratio of 21.31x versus the sector average of 20x, PG stock appears slightly overvalued on this metric. However, its Discounted Cash Flow (DCF) model indicates a fair value of $225.17, suggesting it is significantly undervalued by 52.9% relative to its current price. With a P/S ratio of 3.95x being fair and a P/B ratio of 6.52x being expensive, the overall PG valuation picture is mixed, but the DCF model points to considerable upside potential.

For informational purposes only. Not investment advice. Data: Financial Modeling Prep & SEC EDGAR. Always do your own research.